Related Experiment Video
Updated: Jun 16, 2026
07:00
A Method to Study the C924T Polymorphism of the Thromboxane A2 Receptor Gene
Published on: April 1, 2019
DNA polymorphisms: what they are and their role in human pigmentation
M G Kosmadaki1, A J Stratigos, Ch Antoniou
1Andreas Sygros Hospital, University of Athens, Greece.
Actas Dermo-Sifiliograficas
|January 26, 2010
Summary
Human pigmentation, including skin, hair, and eye color, is influenced by multiple genes. DNA polymorphisms are key genetic variations contributing to these visible phenotypic differences, as highlighted in this review.
Area of Science:
- Genetics
- Human Biology
- Molecular Biology
Background:
- Human pigmentation exhibits significant phenotypic variation, influenced by multiple genes.
- Genetics provides the framework for understanding the correlation between genotype and phenotype.
- Visible traits like skin, hair, and eye color are prime examples of human genetic diversity.
Purpose of the Study:
- To review the role of DNA polymorphisms in human pigmentation.
- To explore the genetic underpinnings of variations in skin, hair, and eye color.
- To synthesize current scientific understanding of genotype-phenotype correlations in pigmentation.
Main Methods:
- Literature review of recent scientific publications.
- Analysis of studies investigating DNA polymorphisms related to pigmentation.
- Synthesis of genetic data and phenotypic observations.
Main Results:
- DNA polymorphisms are identified as significant contributors to human pigmentation variation.
- Specific genetic variations partially explain differences in skin, hair, and eye color.
- The review consolidates evidence linking genotype to pigmentation phenotype.
Conclusions:
- Multiple genes and their polymorphisms are crucial for determining human pigmentation.
- Understanding these genetic variations is key to explaining phenotypic diversity.
- Further research into DNA polymorphisms will enhance our knowledge of human pigmentation genetics.
Related Concept Videos
01:05Single Nucleotide Polymorphisms-SNPs
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
01:27Principles of Pharmacogenetics: Types of Genetic Variants
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
02:26Comparing Copy Number Variations and SNPs
Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:19Pigmentation
The color of the skin is influenced by a number of pigments, including melanin, carotene, and hemoglobin. Recall that melanin is produced by cells called melanocytes, which are found scattered throughout the stratum basale of the epidermis. The melanin is transferred to the keratinocytes via melanosomes.
Melanin occurs in two primary forms: eumelanin that provides black and brown pigment and pheomelanin that provides red color. Dark-skinned individuals produce more melanin than those with pale...
Melanin occurs in two primary forms: eumelanin that provides black and brown pigment and pheomelanin that provides red color. Dark-skinned individuals produce more melanin than those with pale...
01:27Pharmacogenetics of Drug Metabolism: Overview
Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...